Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599336 · ClinicalTrials.gov registry record · NA
RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03599336: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03599336 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03599336, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
There is currently no consensus amongst orthopedic specialists on the best way to treat 3- and 4-part proximal humerus fractures. No surgery and surgery with a type of shoulder replacement called a reverse total shoulder arthroplasty are two options that many orthopedists use. This study is being performed to evaluate the differences in short- and long-term pain and functional outcomes between patients who are treated with these two different options.
Interventions
- PROCEDURE Reverse Total Shoulder Arthroplasty (rTSA)
- OTHER Nonoperative Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03599336
The ClinicalTrials.gov registry entry for NCT03599336 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Reverse Total Shoulder Arthroplasty (rTSA) is the first listed.
NCT03599336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03599336 about?
NCT03599336 is a clinical study titled "RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures". There is currently no consensus amongst orthopedic specialists on the best way to treat 3- and 4-part proximal humerus fractures. No surgery and surgery with a type of shoulder replacement called a reverse total shoulder arthroplasty are two options that many orthopedists use. This study is being pe...
What is the current status of trial NCT03599336?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-08-01. Estimated completion is 2020-10-29.
What interventions are being tested in trial NCT03599336?
The interventions under investigation include: Reverse Total Shoulder Arthroplasty (rTSA) (PROCEDURE), Nonoperative Treatment (OTHER).
Who is sponsoring clinical trial NCT03599336?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.